Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens
Journal of Psychedelic Studies February 25, 2019 Jenna Varley 4 citations
Psychedelics like LSD and psilocybin are being studied again for treating anxiety and depression in terminally ill patients, building on research from the 1960s. Recent clinical trials show higher methodological quality and demonstrate a profound impact for these patients. However, gaps remain in understanding Western views on death, how the psychedelic experience helps those facing death, and how suffering and distress are defined in psychiatry and medicine. This article critically evaluates recent studies and suggests that anthropology can contribute valuable knowledge to this emerging field.